Decision to provide ivermectin (Mectizan) free of charge for river blindness
E140047
The "Decision to provide ivermectin (Mectizan) free of charge for river blindness" was a landmark corporate philanthropy initiative that enabled mass treatment of onchocerciasis in affected regions, dramatically reducing disease burden and blindness in millions of people.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Decision to provide ivermectin (Mectizan) free of charge for river blindness canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T1213875 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
Target entity: Decision to provide ivermectin (Mectizan) free of charge for river blindness Context triple: [Roy Vagelos, notableWork, Decision to provide ivermectin (Mectizan) free of charge for river blindness]
-
A.
Guinea Worm Eradication Program
The Guinea Worm Eradication Program is a global public health initiative led by The Carter Center that aims to eliminate dracunculiasis (Guinea worm disease) through surveillance, community education, and preventive measures rather than vaccination or drug treatment.
-
B.
River Blindness Program
The River Blindness Program is a Carter Center initiative dedicated to eliminating river blindness (onchocerciasis) through mass drug administration, health education, and community-based disease control in affected regions.
-
C.
Roll Back Malaria
Roll Back Malaria is a global partnership initiative aimed at coordinating international efforts to control and eventually eliminate malaria, particularly in the most affected regions.
-
D.
Trachoma Control Program
The Trachoma Control Program is a Carter Center initiative focused on eliminating trachoma, a leading cause of preventable blindness, through community-based treatment, surgery, hygiene promotion, and environmental improvements.
-
E.
Action and Investment to defeat Malaria (AIM)
Action and Investment to defeat Malaria (AIM) is a comprehensive global strategy and investment framework designed to guide and coordinate efforts to eliminate and ultimately eradicate malaria worldwide.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Target entity: Decision to provide ivermectin (Mectizan) free of charge for river blindness Target entity description: The "Decision to provide ivermectin (Mectizan) free of charge for river blindness" was a landmark corporate philanthropy initiative that enabled mass treatment of onchocerciasis in affected regions, dramatically reducing disease burden and blindness in millions of people.
-
A.
Guinea Worm Eradication Program
The Guinea Worm Eradication Program is a global public health initiative led by The Carter Center that aims to eliminate dracunculiasis (Guinea worm disease) through surveillance, community education, and preventive measures rather than vaccination or drug treatment.
-
B.
River Blindness Program
The River Blindness Program is a Carter Center initiative dedicated to eliminating river blindness (onchocerciasis) through mass drug administration, health education, and community-based disease control in affected regions.
-
C.
Roll Back Malaria
Roll Back Malaria is a global partnership initiative aimed at coordinating international efforts to control and eventually eliminate malaria, particularly in the most affected regions.
-
D.
Trachoma Control Program
The Trachoma Control Program is a Carter Center initiative focused on eliminating trachoma, a leading cause of preventable blindness, through community-based treatment, surgery, hygiene promotion, and environmental improvements.
-
E.
Action and Investment to defeat Malaria (AIM)
Action and Investment to defeat Malaria (AIM) is a comprehensive global strategy and investment framework designed to guide and coordinate efforts to eliminate and ultimately eradicate malaria worldwide.
- F. None of above. chosen
Statements (45)
| Predicate | Object |
|---|---|
| instanceOf |
corporate philanthropy initiative
ⓘ
drug donation program ⓘ public health intervention ⓘ |
| addressesVectorBorneDisease | blackfly-transmitted onchocerciasis ⓘ |
| announcedBy | Roy Vagelos ⓘ |
| announcedInYear | 1987 ⓘ |
| contributesTo |
neglected tropical disease control
ⓘ
onchocerciasis elimination goals ⓘ |
| enables |
community-directed treatment with ivermectin
ⓘ
mass drug administration ⓘ |
| hasAdministrationRoute | oral ⓘ |
| hasBeneficiaries | millions of people at risk of onchocerciasis ⓘ |
| hasBrandName | Mectizan ⓘ |
| hasDrug | ivermectin ⓘ |
| hasEthicalSignificance |
landmark in global health philanthropy
ⓘ
model for large-scale drug donation programs ⓘ |
| hasGeographicFocus |
Latin America
ⓘ
Yemen ⓘ Sub-Saharan Africa ⓘ
surface form:
sub-Saharan Africa
|
| hasLongTermImpact |
near-elimination of onchocerciasis in several endemic countries
ⓘ
prevention of new cases of river blindness-related blindness ⓘ |
| hasOutcome |
economic productivity gains in treated regions
ⓘ
improved quality of life in endemic communities ⓘ prevention of severe itching and skin disease ⓘ reduction in onchocerciasis prevalence ⓘ reduction in river blindness-related blindness ⓘ |
| hasPrimaryRegionOfImpact | rural communities near fast-flowing rivers ⓘ |
| hasScope | lifelong donation commitment for as long as needed ⓘ |
| hasTreatmentFrequency |
annual treatment
ⓘ
biannual treatment in some settings ⓘ |
| implementedThrough |
Merck Mectizan Donation Program
ⓘ
surface form:
Mectizan Donation Program
|
| madeBy |
Merck & Co.
ⓘ
Merck & Co. ⓘ
surface form:
Merck Sharp & Dohme
|
| motivatedBy |
corporate social responsibility
ⓘ
lack of affordable treatment options in endemic countries ⓘ |
| partneredWith |
World Bank
ⓘ
World Health Organization ⓘ endemic country ministries of health ⓘ non-governmental organizations ⓘ |
| recognizedAs | one of the largest long-term drug donation programs in history ⓘ |
| supportsProgram |
Onchocerciasis Control Programme in West Africa
ⓘ
surface form:
African Programme for Onchocerciasis Control
Onchocerciasis Control Programme in West Africa ⓘ Onchocerciasis Elimination Program for the Americas ⓘ |
| targetsDisease |
onchocerciasis
ⓘ
river blindness ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Subject: Decision to provide ivermectin (Mectizan) free of charge for river blindness Description of subject: The "Decision to provide ivermectin (Mectizan) free of charge for river blindness" was a landmark corporate philanthropy initiative that enabled mass treatment of onchocerciasis in affected regions, dramatically reducing disease burden and blindness in millions of people.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.